(NYSE: MCK) Mckesson's forecast annual revenue growth rate of 9.59% is forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 7.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.86%.
Mckesson's revenue in 2024 is $313,751,000,000.On average, 6 Wall Street analysts forecast MCK's revenue for 2025 to be $45,780,433,727,519, with the lowest MCK revenue forecast at $45,598,758,529,108, and the highest MCK revenue forecast at $46,190,875,592,076. On average, 6 Wall Street analysts forecast MCK's revenue for 2026 to be $49,950,596,286,924, with the lowest MCK revenue forecast at $48,601,055,152,507, and the highest MCK revenue forecast at $51,196,878,409,296.
In 2027, MCK is forecast to generate $53,409,150,741,986 in revenue, with the lowest revenue forecast at $51,681,409,146,671 and the highest revenue forecast at $54,901,782,402,664.